Items Tagged ‘Zometa’

January 17, 2018

Xgeva Approved for The Treatment of Multiple Myeloma


CancerConnect News: The US Food and Drug Administration (FDA) has expanded the approval of Xgeva (denosumab) for the prevention of skeletal-related events in patients with bone metastasis from multiple myeloma. In multiple myeloma, plasma cells infiltrate the bone marrow, spreading into the cavities of all the large bones of the body. In a majority of […]

View full entry

Tags: Bone Metastases, Multiple Myeloma, News, treatment, Xgeva, Zometa